微波消融在乙肝相关肝癌治疗的进展与挑战
Journal: Basic Medical Theory Research DOI: 10.12238/bmtr.v6i5.10102
Abstract
微波消融技术作为一种治疗肝癌的微创手段,在乙肝病毒感染相关的肝癌治疗中显示出独特的优势。该技术通过发射特定频率的微波能量,在肿瘤组织中产生高温,实现精确定位加热,直至组织完全坏死,同时对周围正常组织的损伤相对较小。与传统治疗方法相比,微波消融能够在较小的切口下进行,减少了手术的全身性影响,并为肝功能不佳的患者提供重要治疗选择。然而,对于较大的肿瘤或位置复杂的肿瘤,如何提高消融效率、降低复发率,以及如何与其他治疗手段有效结合仍需进一步研究。当前的临床实践和研究需要集中于技术的优化、消融效果的最大化以及复发率的降低,以期提升患者的生存质量和总生存期。微波消融技术的应用前景广阔,但需要不断地技术革新和临床实践以提高操作的精准性和安全性,并通过长期随访和研究来评估其长期有效性和安全性。
Keywords
微波消融技术；乙肝相关肝癌；治疗进展；治疗挑战
Full Text
PDF - Viewed/Downloaded: 0 TimesReferences
[1] 渠文静.初治原发性肝癌超声引导下经皮微波消融治疗术后并发症及疗效分析[D].吉林大学,2024.
[2] 中华人民共和国国家卫生健康委员会.原发性肝癌诊疗指南(2024年版)[J]:1-52.
[3] KaiFeng,JunYan,XiaowuLi,etal.Arandomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma[J].Journal of Hepatology,2012,57:794-802.
[4] Juan Xu,Ye Zhao2Departments of 1Ultrasound,2Orthope dics, et al. Original Article Comparison of percutaneous micr owave ablation and laparoscopic resection in the prognosis of liver cancer[J].1-5.
[5] 何华.探索肝癌风险人群危险分层和制定肝癌分层筛查策略的研究_何华[D].吉林大学,2023
[6] openaccess to scientifc,medical research. The Mechani sms of HBV-Induced Hepatocellular Carcinoma[Z]:1-16.
[7] Tito Livraghi,Franca Meloni,Michele Di Stasi, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcin oma in cirrhosis: Is resection still the treatment of choice? [J].Hepatology,2007,47:82-89.
[8] Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller a retrospective comparative study[J].
[9] Naïk Vietti Violi,Rafael Duran,Boris Guiu,etal. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chron ic liver disease: a randomised controlled phase 2 trial[J]. TheLancet Gastroenterology & Hepatology,2018,3:317-325.
[10] Jie Yu,Xiao-ling Yu,Zhi-yu Han, et al. Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial[J].Gut,2017,66:1172-1173.
[11] S-M Lin.Randomised controlled trial comparing perc utaneous radiofrequency thermal ablation, percutaneous eth anol injection, and percutaneous acetic acid injection to tre at hepatocellular carcinoma of 3 cm or less[J]. Gut, 2005, 54:1151-1156.
[12] 柳明,刘超,李成利,等.影像引导肝癌的冷冻消融治疗专家共识(2020版)[J].中国医刊,2020,55(05):489-492.
[2] 中华人民共和国国家卫生健康委员会.原发性肝癌诊疗指南(2024年版)[J]:1-52.
[3] KaiFeng,JunYan,XiaowuLi,etal.Arandomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma[J].Journal of Hepatology,2012,57:794-802.
[4] Juan Xu,Ye Zhao2Departments of 1Ultrasound,2Orthope dics, et al. Original Article Comparison of percutaneous micr owave ablation and laparoscopic resection in the prognosis of liver cancer[J].1-5.
[5] 何华.探索肝癌风险人群危险分层和制定肝癌分层筛查策略的研究_何华[D].吉林大学,2023
[6] openaccess to scientifc,medical research. The Mechani sms of HBV-Induced Hepatocellular Carcinoma[Z]:1-16.
[7] Tito Livraghi,Franca Meloni,Michele Di Stasi, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcin oma in cirrhosis: Is resection still the treatment of choice? [J].Hepatology,2007,47:82-89.
[8] Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller a retrospective comparative study[J].
[9] Naïk Vietti Violi,Rafael Duran,Boris Guiu,etal. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chron ic liver disease: a randomised controlled phase 2 trial[J]. TheLancet Gastroenterology & Hepatology,2018,3:317-325.
[10] Jie Yu,Xiao-ling Yu,Zhi-yu Han, et al. Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial[J].Gut,2017,66:1172-1173.
[11] S-M Lin.Randomised controlled trial comparing perc utaneous radiofrequency thermal ablation, percutaneous eth anol injection, and percutaneous acetic acid injection to tre at hepatocellular carcinoma of 3 cm or less[J]. Gut, 2005, 54:1151-1156.
[12] 柳明,刘超,李成利,等.影像引导肝癌的冷冻消融治疗专家共识(2020版)[J].中国医刊,2020,55(05):489-492.
Copyright © 2024 刘娣, 任宾
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
